* Zepp Health Corp ZEPP.N ZEPP.K is expected to show a
fall in
quarterly revenue when it reports results on August 25.
* The Hefei Anhui-based company is expected to report a
40.5% decrease in revenue to CNY1.091 billion from CNY1.84
billion a year ago, according to the estimate from one analyst,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Zepp Health Corp is
for a
loss of CNY1.32 per share. For the same quarter last year, the
company reported earnings of CNY2.01 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Zepp Health
Corp
is $4.6, above its last closing price of $1.96.
This summary was machine generated August 23 at 15:12 GMT. All
figures in Chinese yuan renminbi unless otherwise stated